CECCATO, FILIPPO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.805
AS - Asia 4.300
EU - Europa 3.449
SA - Sud America 1.201
AF - Africa 941
OC - Oceania 109
Continente sconosciuto - Info sul continente non disponibili 43
AN - Antartide 1
Totale 19.849
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.220
SG - Singapore 1.317
IT - Italia 989
CN - Cina 863
BR - Brasile 819
HK - Hong Kong 699
DE - Germania 382
VN - Vietnam 306
FI - Finlandia 209
NL - Olanda 183
PL - Polonia 166
GB - Regno Unito 158
RU - Federazione Russa 150
SE - Svezia 128
KR - Corea 125
FR - Francia 124
AT - Austria 95
IN - India 84
MX - Messico 71
CI - Costa d'Avorio 68
IE - Irlanda 66
TR - Turchia 66
UA - Ucraina 66
CA - Canada 65
EC - Ecuador 60
AR - Argentina 58
IQ - Iraq 50
CL - Cile 49
ZA - Sudafrica 48
JP - Giappone 47
PE - Perù 42
ES - Italia 41
CO - Colombia 39
CR - Costa Rica 39
PY - Paraguay 39
BE - Belgio 37
HU - Ungheria 35
NO - Norvegia 35
AL - Albania 34
CH - Svizzera 34
KE - Kenya 34
MD - Moldavia 34
BY - Bielorussia 33
IL - Israele 33
LC - Santa Lucia 33
ME - Montenegro 33
KG - Kirghizistan 32
MR - Mauritania 32
BF - Burkina Faso 31
EE - Estonia 31
GR - Grecia 31
ID - Indonesia 31
PA - Panama 31
BZ - Belize 30
EG - Egitto 30
GH - Ghana 30
GT - Guatemala 30
JM - Giamaica 30
MA - Marocco 30
PH - Filippine 30
RO - Romania 30
BA - Bosnia-Erzegovina 29
NZ - Nuova Zelanda 29
LA - Repubblica Popolare Democratica del Laos 28
LY - Libia 28
NC - Nuova Caledonia 28
SA - Arabia Saudita 28
UY - Uruguay 28
AE - Emirati Arabi Uniti 27
AZ - Azerbaigian 27
BD - Bangladesh 27
MY - Malesia 27
VE - Venezuela 27
BS - Bahamas 26
CZ - Repubblica Ceca 26
DO - Repubblica Dominicana 26
GE - Georgia 26
KZ - Kazakistan 26
LB - Libano 26
MK - Macedonia 26
ML - Mali 26
PT - Portogallo 26
RS - Serbia 26
TH - Thailandia 26
BB - Barbados 25
JO - Giordania 25
NE - Niger 25
PK - Pakistan 25
TW - Taiwan 25
AD - Andorra 24
AO - Angola 24
GM - Gambi 24
HN - Honduras 24
SK - Slovacchia (Repubblica Slovacca) 24
TJ - Tagikistan 24
XK - ???statistics.table.value.countryCode.XK??? 24
BJ - Benin 23
BW - Botswana 23
DJ - Gibuti 23
GN - Guinea 23
Totale 18.769
Salva come PNG Salva come JPEG
Città #
Fairfield 1.367
Ashburn 1.094
Singapore 869
Woodbridge 724
Hong Kong 668
Chandler 638
Houston 574
Cambridge 503
Ann Arbor 489
Seattle 488
Wilmington 378
Beijing 254
Santa Clara 239
Boardman 234
Padova 168
San Diego 152
Hefei 151
Princeton 121
Munich 116
Bytom 115
Milan 115
Medford 110
Seoul 103
Helsinki 102
Dong Ket 98
Los Angeles 98
Des Moines 87
New York 79
Ho Chi Minh City 73
São Paulo 72
Abidjan 63
Buffalo 62
Nuremberg 61
Roxbury 57
Dublin 55
Redondo Beach 54
Vienna 51
Hanoi 47
Rome 43
Jacksonville 42
Nanjing 39
London 37
Turku 35
Castries 33
Brooklyn 32
San José 31
Frankfurt am Main 30
Nouakchott 30
Panama City 30
Villafranca Padovana 30
Chicago 29
Accra 28
Nairobi 27
Noumea 27
Quito 27
Bishkek 26
Nassau 26
Padua 26
Ouagadougou 25
Podgorica 25
Rio de Janeiro 25
Istanbul 24
Luanda 24
Montevideo 24
Baku 23
Conakry 23
Dushanbe 23
Lappeenranta 23
Managua 23
Mexico City 23
Tallinn 23
Warsaw 23
Amman 22
Andorra la Vella 22
Bamako 22
Bridgetown 22
Djibouti 22
Kampala 22
Lima 22
Minsk 22
Auckland 21
Johannesburg 21
Niamey 21
Vientiane 21
Cotonou 20
Dallas 20
Libreville 20
Phnom Penh 20
Shenyang 20
Tbilisi 20
Tokyo 20
Athens 19
Brasília 19
San Francisco 19
Ulan Bator 19
Baghdad 18
Belo Horizonte 18
Chisinau 18
Guatemala City 18
Kingston 18
Totale 12.254
Salva come PNG Salva come JPEG
Nome #
A constitutive active MAPK/ERK pathway due to BRAFV600E positively regulates AHR pathway in PTC 243
Paradoxical GH increase during OGTT is associated to first-generation somatostatin analogs responsiveness in acromegaly 232
Personalized medical treatment for pituitary adenoma 220
THE NATURAL HISTORY OF AUTOIMMUNE ADDISON'S DISEASE FROM THE DETECTION OF AUTOANTIBODIES TO DEVELOPMENT OF THE DISEASE: A LONG FOLLOW-UP STUDY ON 143 PATIENTS 208
Diagnosis and complications of Cushing's disease: gender-related differences. 204
Letter to Editor: Reply to R.T. Casey (Semin Oncol. 2018 Jun;45(3):151-155) 196
Effects of pasireotide treatment on coagulative profile: a prospective study in patients with Cushing’s disease 193
Improved salivary cortisol rhythm with dual-release hydrocortisone 191
Activation of the Dopamine Receptor Type-2 (DRD2) Promoter by 9-Cis Retinoic Acid in a Cellular Model of Cushing's Disease Mediates the Inhibition of Cell Proliferation and ACTH Secretion Without a Complete Corticotroph-to-Melanotroph Transdifferentiation 184
Temozolomide cytoreductive treatment in a giant cabergoline-resistant prolactin-secreting pituitary neuroendocrine tumor 183
AHR over-expression in papillary thyroid carcinoma: clinical and molecular assessments in a series of Italian acromegalic patients with a long-term follow-up 183
An analysis of different therapeutic options in patients with Cushing's syndrome due to bilateral macronodular adrenal hyperplasia: A single-centre experience 182
Perioperative multidisciplinary management of endoscopic transsphenoidal surgery for sellar lesions: practical suggestions from the Padova model 182
Screening tests for cushing's syndrome: Urinary free cortisol role measured by LC-MS/MS 181
A venous thromboembolism risk assessment model for patients with Cushing’s syndrome 180
First-line screening tests for Cushing's syndrome in patients with adrenal incidentaloma: the role of urinary free cortisol measured by LC-MS/MS 180
Age and the metabolic syndrome affect salivary cortisol rhythm: Data from a community sample 179
Early recognition of aggressive pituitary adenomas: a single-centre experience 176
Aldosterone in Gynecology and Its Involvement on the Risk of Hypertension in Pregnancy 176
Temozolomide therapy in patients with aggressive pituitary adenomas or carcinomas 175
Metyrapone treatment in Cushing’s syndrome: a real-life study 175
Clinical presentation and management of acromegaly in elderly patients 172
Long-term glucocorticoid effect on bone mineral density in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency 164
Adrenal lesions in acromegaly: do metabolic aspects and aryl hydrocarbon receptor interacting protein gene have a role? Evaluation at baseline and after long-term follow-up. 163
Temozolomide and pasireotide treatment for aggressive pituitary adenoma: expertise at a tertiary care center. 163
Acromegaly Is More Severe in Patients With AHR or AIP Gene Variants Living in Highly Polluted Areas 161
Diagnostic performance of salivary cortisol in the diagnosis of Cushing's syndrome, adrenal incidentaloma and adrenal insufficiency. 161
Secondary Arterial Hypertension: From Routine Clinical Practice to Evidence in Patients with Adrenal Tumor 160
Second-line tests in the differential diagnosis of ACTH-dependent Cushing’s syndrome 158
Intracranial internal carotid artery changes in acromegaly: a quantitative magnetic resonance angiography study. 155
Daily salivary cortisol and cortisone rhythm in patients with adrenal incidentaloma 155
Decrease in salivary cortisol levels after glucocorticoid dose reduction in patients with adrenal insufficiency: A prospective proof-of-concept study 155
Combination therapy for Cushing's disease: effectiveness of two schedules of treatment. Should we start with cabergoline or ketoconazole? 154
A multicenter experience on the prevalence of ARMC5 mutations in patients with primary bilateral macronodular adrenal hyperplasia: from genetic characterization to clinical phenotype 153
Medical Treatment for Acromegaly does not Increase the Risk of Central Adrenal Insufficiency: A Long-Term Follow-Up Study 153
Human Corticotropin-Releasing Hormone tests: 10 years of real-life experience in pituitary and adrenal disease 150
Low-dose short synacthen test with salivary cortisol in patients with suspected central adrenal insufficiency 150
Evaluation of angiotensin II type-1 receptor antibodies in primary aldosteronism and further considerations about their possible pathogenetic role 149
Prevalence of AIP mutations in a large series of sporadic Italian acromegalic patients and evaluation of CDKN1B status in acromegalic patients with multiple endocrine neoplasia. 147
Radiotherapy in acromegaly: Long-term brain parenchymal and vascular magnetic resonance changes 140
The Pathophysiology and Treatment of Hypertension in Patients With Cushing's Syndrome 138
Dexamethasone measurement during low-dose suppression test for suspected hypercortisolism: threshold development and validation 138
The Methylation Analysis of the Glucose-Dependent Insulinotropic Polypeptide Receptor (GIPR) Locus in GH-Secreting Pituitary Adenomas. 137
Gonadotropin secreting pituitary adenoma associated with erythrocytosis: case report and literature review. 137
Cardiovascular autonomic dysfunction in patients with idiopathic diabetes insipidus 137
Monogenic Forms of Hypertension 134
The diagnostic performance of urinary free cortisol is better than the cortisol:cortisone ratio in detecting de novo Cushing's syndrome: the use of a LC-MS/MS method in routine clinical practice 133
Therapeutic strategies for Cushing's syndrome: An update 133
The R304X mutation of the Aryl hydrocarbon receptor Interacting Protein gene in familial isolated pituitary adenomas: mutational Hot-Spot or founder effect? 132
Allelic Variants of ARMC5 in Patients With Adrenal Incidentalomas and in Patients With Cushing's Syndrome Associated With Bilateral Adrenal Nodules 132
The GIP/GIPR axis is functionally linked to GH-secretion increase in a significant proportion of gsp(-) somatotropinomas 127
Body Composition is Different after Surgical or Pharmacological Remission of Cushing's Syndrome: A Prospective DXA Study 126
Increased rate of intracranial saccular aneurysms in acromegaly: an MR angiography study and review of the literature. 126
Attenuation Value in Adrenal Incidentalomas: A Longitudinal Study 124
Diagnostic accuracy of increased urinary cortisol/cortisone ratio to differentiate ACTH dependent Cushing's syndrome 123
Is pasireotide-induced diabetes mellitus predictable? A pilot study on the effect of a single dose of pasireotide on glucose homeostasis 123
First Evidence of Mineralocorticoid Receptor Gene and Protein Expression in Rat and Human Thyroid Tissues and Cell Cultures 122
Assessment of glucocorticoid therapy with salivary cortisol in secondary adrenal insufficiency. 121
Rapid disease progression in patient with mismatch-repair deficiency pituitary ACTH-secreting adenoma treated with checkpoint inhibitor pembrolizumab 121
Pitfalls in urinary sodium excretion 121
Long-course temozolomide in aggressive pituitary adenoma: real-life experience in two tertiary care centers and review of the literature 121
Diagnostic Accuracy of CT Texture Analysis in Adrenal Masses: A Systematic Review 121
The diagnostic accuracy of increased late night salivary cortisol for Cushing’s syndrome: a real-life prospective study 120
Treatment of aggressive pituitary tumours and carcinomas: Results of a European Society of Endocrinology (ESE) survey 2016 120
Predicting late recurrence in surgically-treated patients with Cushing's disease. 119
CT Texture Analysis of Adrenal Pheochromocytomas: A Pilot Study 118
Serological Evidence and Self-reported Outcomes in Patients with Adrenal Insufficiency during the first waves of COVID-19 in the North-East Italy 118
Mitotane Concentrations Influence the Risk of Recurrence in Adrenocortical Carcinoma Patients on Adjuvant Treatment 118
Genetica delle forme di iperplasia bilaterale del surrene secernenti cortisolo 117
The role of an acute pasireotide suppression test in predicting response to treatment in patients with Cushing's disease: findings from a pilot study. 116
Salivary cortisol and cortisone by LC-MS/MS: Validation, reference intervals and diagnostic accuracy in Cushing's syndrome 116
The haemostatic system in acromegaly: a single-centre case–control study 116
Pituitary-adrenal axis and peripheral cortisol metabolism in obese patients 116
La terapia medica della Malattia di Cushing: presente e futuro 115
The role of 68Ga-DOTA derivatives PET-CT in patients with ectopic ACTH syndrome 113
The diagnostic accuracy of adjusted unconventional indices for adrenal vein sampling in the diagnosis of primary aldosteronism subtypes 113
Radiomics: a new tool to differentiate adrenocortical adenoma from carcinoma 110
The paradoxical GH response at OGTT does not predict Pasireotide efficacy but matters for glucose metabolism 110
Perioperative thromboprophylaxis in Cushing's disease: What we did and what we are doing? 109
Anastrozole as add-on therapy for cabergoline-resistant prolactin-secreting pituitary adenomas: real-life experience in male patients 109
Approach to hyponatremia according to the clinical setting: Consensus statement from the Italian Society of Endocrinology (SIE), Italian Society of Nephrology (SIN), and Italian Association of Medical Oncology (AIOM) 108
Cortisone salivare al risveglio nella diagnosi dell’insufficienza surrenalica 106
Linfoma surrenalico primitivo: l’importanza di riconoscere una patologia spesso dimenticata 102
RNA-Sequencing and Somatic Mutation Status of Adrenocortical Tumors: Novel Pathogenetic Insights 101
Silent gonadotroph pituitary neuroendocrine tumor in a patient with tuberous sclerosis complex: evaluation of a possible molecular link 100
Carney Complex in clinical practice 100
Cushing's Syndrome: Screening and Diagnosis 99
Tele-medicine versus face-to-face consultation in Endocrine Outpatients Clinic during COVID-19 outbreak: a single-center experience during the lockdown period 98
Central adrenal insufficiency: open issues regarding diagnosis and glucocorticoid treatment 98
Frequently asked questions and answers (if any) in patients with adrenal incidentaloma 98
A schedule for tapering glucocorticoid treatment in patients with severe SARS-CoV 2 infection can prevent acute adrenal insufficiency in the geriatric population 98
Test di soppressione al fludrocortisone ambulatoriale nella diagnostica dell’iperaldosteronismo primitivo 97
A multidisciplinary approach to the management of adrenal incidentaloma 97
Frequently Asked Questions in Patients With Adrenal Insufficiency in the Time of COVID-19 96
Clinical use of pasireotide for Cushing's disease in adults. 95
Corticotroph Tumor Progression after Bilateral Adrenalectomy (Nelson's syndrome): Systematic Review and Expert Consensus Recommendations 95
Could CT Radiomic Analysis of Benign Adrenal Incidentalomas Suggest the Need for Further Endocrinological Evaluation? 94
Sleep apnea syndrome in endocrine clinics 94
Somatostatin analogues increase AIP expression in somatotropinomas, irrespective of Gsp mutations. 93
Indication to dynamic and invasive testing in Cushing’s disease according to different neuroradiological findings 93
Totale 13.848
Salva come PNG Salva come JPEG
Categoria #
all - tutte 74.209
article - articoli 72.387
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.036
Totale 147.632
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.434 0 0 188 77 54 57 60 132 196 210 186 274
2021/20221.812 68 157 178 134 169 122 78 210 111 57 132 396
2022/20231.302 283 181 26 158 161 137 11 94 125 30 67 29
2023/20241.192 29 123 120 98 107 133 142 97 41 32 124 146
2024/20255.049 45 362 186 222 561 140 291 434 443 242 753 1.370
2025/20265.846 1.216 1.866 2.764 0 0 0 0 0 0 0 0 0
Totale 20.205